FI873924A - Foerfarande foer framstaellning av aettiksyraestern av haloperidol och denna innehaollande farmaceutiska preparat. - Google Patents
Foerfarande foer framstaellning av aettiksyraestern av haloperidol och denna innehaollande farmaceutiska preparat. Download PDFInfo
- Publication number
- FI873924A FI873924A FI873924A FI873924A FI873924A FI 873924 A FI873924 A FI 873924A FI 873924 A FI873924 A FI 873924A FI 873924 A FI873924 A FI 873924A FI 873924 A FI873924 A FI 873924A
- Authority
- FI
- Finland
- Prior art keywords
- haloperidol
- aettiksyraestern
- denna
- och
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8621892 | 1986-09-11 | ||
GB868621892A GB8621892D0 (en) | 1986-09-11 | 1986-09-11 | Organic compound |
Publications (4)
Publication Number | Publication Date |
---|---|
FI873924A0 FI873924A0 (fi) | 1987-09-10 |
FI873924A true FI873924A (fi) | 1988-03-12 |
FI88155B FI88155B (fi) | 1992-12-31 |
FI88155C FI88155C (fi) | 1993-04-13 |
Family
ID=10604021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI873924A FI88155C (fi) | 1986-09-11 | 1987-09-10 | Foerfarande foer framstaellning av en terapeutiskt anvaendbar aettiksyraester av 4-(4-(4-klorfenyl)-4-hydroxi-1-piperidinyl)-1-(4-fluorfenyl)-1-butanon |
Country Status (16)
Country | Link |
---|---|
US (1) | US4855307A (fi) |
EP (1) | EP0260070B1 (fi) |
JP (1) | JPS6377857A (fi) |
AT (1) | ATE92917T1 (fi) |
AU (1) | AU591334B2 (fi) |
DE (1) | DE3786966T2 (fi) |
DK (1) | DK166320C (fi) |
ES (1) | ES2058120T3 (fi) |
FI (1) | FI88155C (fi) |
GB (1) | GB8621892D0 (fi) |
IE (1) | IE60902B1 (fi) |
IL (1) | IL83819A (fi) |
NO (1) | NO169893C (fi) |
NZ (1) | NZ221711A (fi) |
PT (1) | PT85678B (fi) |
ZA (1) | ZA876819B (fi) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3742580C1 (de) * | 1987-12-16 | 1989-05-11 | Schaper & Bruemmer Gmbh | Verwendung des alpha,alpha-Diphenyl-alpha-(3-carboxy-propionyloxy)-essigsaeure-4-(N-methylpiperidyl)-esters zur Behandlung hypertoner Funktionszustaende im Bereich der Harnblase |
US5776963A (en) | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
DK238190D0 (da) * | 1990-10-03 | 1990-10-03 | Lundbeck & Co As H | Depotderivater |
EP1787984B1 (en) * | 2000-03-06 | 2016-10-19 | Acadia Pharmaceuticals Inc. | Azacyclic compounds for use in the treatment of serotonin related diseases |
WO2001066521A1 (en) | 2000-03-06 | 2001-09-13 | Acadia Pharmaceuticals, Inc. | Azacyclic compounds for use in the treatment of serotonin related diseases |
WO2003057698A2 (en) | 2001-12-28 | 2003-07-17 | Acadia Pharmaceuticals, Inc. | Spiroazacyclic compounds as monoamine receptor modulators |
US7538222B2 (en) | 2002-06-24 | 2009-05-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
US7253186B2 (en) | 2002-06-24 | 2007-08-07 | Carl-Magnus Andersson | N-substituted piperidine derivatives as serotonin receptor agents |
IL165907A0 (en) | 2002-06-24 | 2006-01-15 | Acadia Pharm Inc | N-substituted piperidine derivatives as serotonin receptor agents |
PT1587789E (pt) | 2003-01-16 | 2008-12-16 | Acadia Pharm Inc | Agonistas inversos selectivos para receptores 2a/2c da serotonina como agentes terapêuticos para doenças neurodegenerativas |
US20050261278A1 (en) | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
US7820695B2 (en) | 2004-05-21 | 2010-10-26 | Acadia Pharmaceuticals, Inc. | Selective serotonin receptor inverse agonists as therapeutics for disease |
CN101035759B (zh) | 2004-09-27 | 2011-06-15 | 阿卡蒂亚药品公司 | N-(4-氟苄基)-n-(1-甲基哌啶-4-基)-n’-(4-(2-甲基丙氧基)苯基甲基)脲及其酒石酸盐的合成和晶形 |
US7790899B2 (en) | 2004-09-27 | 2010-09-07 | Acadia Pharmaceuticals, Inc. | Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
ES2423485T3 (es) | 2007-03-19 | 2013-09-20 | Acadia Pharmaceuticals Inc. | Asociaciones de agonistas y antagonistas inversos 5-HT2A con antipsicóticos |
SI3325444T1 (sl) | 2015-07-20 | 2021-11-30 | Acadia Pharmaceuticals Inc. | Postopki za pripravo N-(4-fluorobenzil)-N-(1-metilpiperidin-4-il)-N'- (4-(2-metilpropiloksi)fenilmetil)karbamida in njegove tartratne soli in polimorfne oblike C |
WO2017165635A1 (en) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome p450 modulators |
US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
EP3558311A1 (en) | 2016-12-20 | 2019-10-30 | Acadia Pharmaceuticals Inc. | Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis |
US11135211B2 (en) | 2017-04-28 | 2021-10-05 | Acadia Pharmaceuticals Inc. | Pimavanserin for treating impulse control disorder |
US20210077479A1 (en) | 2017-08-30 | 2021-03-18 | Acadia Pharmaceuticals Inc. | Formulations of pimavanserin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB895309A (en) * | 1959-11-18 | 1962-05-02 | Res Lab Dr C Janssen Nv | Pyrrolidine and piperidine derivatives |
US3408356A (en) * | 1965-08-31 | 1968-10-29 | Squibb & Sons Inc | Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like |
DE1695194A1 (de) * | 1966-07-11 | 1971-03-18 | Hoffmann La Roche | Verfahren zur Herstellung von Piperidinderivaten |
US4070473A (en) * | 1973-01-26 | 1978-01-24 | Ab Ferrosan | Piperidino-butyrophenones |
JPS568318A (en) * | 1979-06-28 | 1981-01-28 | Janssen Pharmaceutica Nv | Non oral long acting composition of haloperidol and bromperidol derivative |
-
1986
- 1986-09-11 GB GB868621892A patent/GB8621892D0/en active Pending
-
1987
- 1987-09-03 EP EP87307799A patent/EP0260070B1/en not_active Expired - Lifetime
- 1987-09-03 IE IE236687A patent/IE60902B1/en not_active IP Right Cessation
- 1987-09-03 ES ES87307799T patent/ES2058120T3/es not_active Expired - Lifetime
- 1987-09-03 DE DE87307799T patent/DE3786966T2/de not_active Expired - Lifetime
- 1987-09-03 AT AT87307799T patent/ATE92917T1/de not_active IP Right Cessation
- 1987-09-04 US US07/093,404 patent/US4855307A/en not_active Expired - Lifetime
- 1987-09-08 IL IL83819A patent/IL83819A/xx not_active IP Right Cessation
- 1987-09-08 NZ NZ221711A patent/NZ221711A/xx unknown
- 1987-09-10 FI FI873924A patent/FI88155C/fi not_active IP Right Cessation
- 1987-09-10 NO NO873785A patent/NO169893C/no unknown
- 1987-09-10 PT PT85678A patent/PT85678B/pt not_active IP Right Cessation
- 1987-09-10 AU AU78232/87A patent/AU591334B2/en not_active Ceased
- 1987-09-11 ZA ZA876819A patent/ZA876819B/xx unknown
- 1987-09-11 JP JP62226744A patent/JPS6377857A/ja active Pending
- 1987-09-11 DK DK479587A patent/DK166320C/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3786966T2 (de) | 1994-03-17 |
DK166320C (da) | 1993-08-23 |
ATE92917T1 (de) | 1993-08-15 |
IE60902B1 (en) | 1994-08-24 |
IL83819A0 (en) | 1988-02-29 |
FI88155C (fi) | 1993-04-13 |
IL83819A (en) | 1992-02-16 |
NO169893B (no) | 1992-05-11 |
IE872366L (en) | 1988-03-11 |
JPS6377857A (ja) | 1988-04-08 |
NO873785L (no) | 1988-03-14 |
NZ221711A (en) | 1989-11-28 |
AU7823287A (en) | 1988-03-17 |
FI873924A0 (fi) | 1987-09-10 |
AU591334B2 (en) | 1989-11-30 |
PT85678B (pt) | 1990-05-31 |
EP0260070A1 (en) | 1988-03-16 |
DE3786966D1 (de) | 1993-09-16 |
EP0260070B1 (en) | 1993-08-11 |
ZA876819B (en) | 1988-06-29 |
NO873785D0 (no) | 1987-09-10 |
FI88155B (fi) | 1992-12-31 |
DK166320B (da) | 1993-04-05 |
US4855307A (en) | 1989-08-08 |
DK479587A (da) | 1988-03-12 |
DK479587D0 (da) | 1987-09-11 |
GB8621892D0 (en) | 1986-10-15 |
PT85678A (en) | 1987-10-01 |
ES2058120T3 (es) | 1994-11-01 |
NO169893C (no) | 1992-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI873924A (fi) | Foerfarande foer framstaellning av aettiksyraestern av haloperidol och denna innehaollande farmaceutiska preparat. | |
FI20000507A (fi) | (+)-1-(3-dimetyyliaminopropyyli)-1-(4'-fluorifenyyli)-1,3-dihydroisobentsofuraani-5-karbonitriili ja sitä sisältävä farmaseuttinen koostumus | |
ES2074846T3 (es) | Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
JPS5564571A (en) | Novel 1*44dihydropyridine compound having substituted ester group | |
DE68919341D1 (de) | Verfahren zur Herstellung von Fasern aus Polyvinylalkohol- Zusammensetzungen. | |
DK157013C (da) | Analogifremgangsmaade til fremstilling af fluorholdige 1,4-dihydropyridiner eller farmaceutisk acceptable syreadditionssalte deraf | |
DE69122866D1 (de) | Herstellung von substituierten piperidinen | |
ATE46146T1 (de) | Phenylpiperidinderivat und seine salze, ihre herstellung, sie enthaltende zusammensetzungen und ihre therapeutische verwendung. | |
DE3870221D1 (de) | Konservierende elemente enthaltende organische borverbindungen und die verwendung davon. | |
FI851932A0 (fi) | --karbolin-3- karboxylsyraderivat, deras framstaellningsfoerfarande och deras anvaendning. | |
FI881609A (fi) | Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
DE58905079D1 (de) | Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung. | |
ATE78693T1 (de) | Ein dideoxynukleosid enthaltendes arzneimittel. | |
DE69231883D1 (de) | 4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten | |
DE69218414D1 (de) | Verfahren zur herstellung von trans-piperidin-2,5-dicarboxylaten | |
DE69715733D1 (de) | Verfahren zur Herstellung von 5-Brom-2-Fluorbenzolboronsäure | |
ATE90095T1 (de) | Optisch aktive produkte von 20,21dinoreburnamenin-derivaten,verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen. | |
PT87071A (pt) | Calciumlactat-glycerin-addukt verfahren zu seiner herstellung sowie seine verwendung | |
DK468385D0 (da) | Fremgangsmaade til fremstilling af den optiske d-isomer af diastereomeren aeaae af 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester | |
SE8505801D0 (sv) | 1,4-dihydropyridin-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen | |
EP0169470A3 (de) | Neues Kombinationspräparat, Verfahren zu seiner Hestellung und seine Verwendung als Arzneimittel | |
ATE4166T1 (de) | Langwirkende injizierbare sulfonamidzusammensetzungen. | |
ATE111732T1 (de) | Verwendung von 1,4-dihydropyridinen zur herstellung eines arzneimittels, zur behandlung von neuropathien, die durch diabetes mellitus verursacht sind. | |
DE3670629D1 (de) | Ester von cyclopropancarbonsaeure und 2,3-dihydro-4-phenyl-1h-inden-2-ol, ihre herstellung, ihre verwendung als parasitizide und sie enthaltende zusammensetzungen. | |
IT8705108A0 (it) | Derivati di estere fosforico e composizioni insetticida e acaricida contenenti tali derivati. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: H. LUNDBECK A/S |